Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

Go back to Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue
(NASDAQ: GLUE) Delayed: 14.30 -0.48 (3.25%)
Previous Close $14.78    52 Week High $ 
Open $14.80    52 Week Low $ 
Day High $15.00    P/E N/A 
Day Low $14.17    EPS $ 
Volume 969,159